Pregnancy, HIV and Antiretroviral Therapy on Iron Metabolism in Côte d’Ivoire

Mathieu Nahounou BLEYERE^1, , Soualio KAGAMATE¹, Léandre Kouakou KOUAKOU¹, Sylvie DOUMATEY², Duni SAWADOGO² and Paul Angoué YAPO¹

¹Laboratoire of haematology, Training and Research Unit of the Biological and Pharmaceutical Sciences, Félix Houphouët-Boigny University; Abidjan. Côte d’Ivoire

²3Laboratoire of haematology, Training and Research Unit of the Biological and Pharmaceutical Sciences, Félix Houphouët-Boigny University; Abidjan. Côte d’Ivoire

Cite this paper:
Mathieu Nahounou BLEYERE, Soualio KAGAMATE, Léandre Kouakou KOUAKOU, Sylvie DOUMATEY, Duni SAWADOGO and Paul Angoué YAPO. Pregnancy, HIV and Antiretroviral Therapy on Iron Metabolism in Côte d’Ivoire. International Journal of Clinical Nutrition. 2013; 1(1):1-10. doi: 10.12691/ijcn-1-1-1

Abstract

During pregnancy different metabolic pathways of iron are strongly altered. The main purpose of this investigation is to assess, identify and characterize interaction of the three trimesters of pregnancy, HIV and antiretroviral therapy on the biological indicators of metabolism iron. In this study, 405 women divided into three groups of pregnant women in different trimesters of pregnancy, namely control pregnant women considered apparently healthy, HIV infected pregnant women without antiretroviral therapy and HIV infected pregnant women on antiretroviral therapy for at least one year. Blood samples were carried out in a tube with anticoagulant in each of pregnant women to determine haematological parameters. Blood samples collected on a dry tube were used to determine HIV status and various biochemical indicators of iron metabolism assessment. Results of study showed that haematological and biochemical parameters were altered during the three trimesters of pregnancy in all selected pregnant women. Haematological parameters, serum iron, serum transferrin, TIBC and serum ferritin were strongly degraded in last trimester of infected pregnant women without antiretroviral therapy compared with other pregnant women. In addition, infected pregnant women without antiretroviral therapy revealed a highest prevalence of normal iron status than the other two pregnant women groups (37.1 %, 20.8 % and 8 % respectively). Furthermore, iron deficiency, iron deficiency anaemia, inflammatory anaemia and inflammatory anaemia associated with iron deficiency have been identified as components of iron status. This study reveals that the interaction of pregnancy, HIV and antiretroviral therapy was observed in all selected pregnant women for most determined biological parameters. This observation is critical for HIV infected pregnant women with ARVT. However, infected pregnant women without antiretroviral therapy reported a high prevalence of inflammatory anaemia.

Keywords:
iron metabolism iron deficiency anaemia inflammatory anaemia HIV antiretroviral therapy pregnancy; Côte d’Ivoire

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

References:

[1]	Dallman, P.R, Iron deficiency in the Weanling: a nutritionnal problem on the way to resolution, Acta Paediatrica Scandinavica, 323:59-67. 1986.
[2]	Dallman, P.R, Iron deficiency and the immune response, American Journal of Clinical Nutrition, 46:329-314. 1987.
[3]	Cook, M, Adaptation in iron metabolism, American Journal of Clinical Nutrition, 51:301- 25. 1990.
[4]	UNICEF/UNU/WHO, Déclaration conjointe de l’Organisation Mondiale de la Santé et du Fonds des Nations Unies pour l’Enfance: Focaliser sur l’anémie, vers une approche intégrée pour un contrôle efficace de l’anémie, 2005. Available at: http:/www.who.org/publications/index.html [accessed Apr. 5, 2012].
[5]	Liao, Q.K, Prevalence of iron deficiency in pregnant and premenopausal women in China: a nationwide epidemiological survey, Zhonghua xueyexue zazhi Zhongguo yi xue ke xue yuan, 25 (11):653-7. 2004.
[6]	Bleyere, N., Ekaza-Joulia, D., Yapo, P.A, N’guessan, B.B., Neil, C.A.M., Vanga, M.O., Koné, M. and Ehilé, E.E, Hétérogénéité du statut en fer chez la femme au cours de la grossesse en Cote d’Ivoire, Annale de Biologie Clinique, 65(5): 525-532. 2007.
[7]	Vanderjagt, D.J., Brock, H.S., Melah, G.S., El-Nafaty, A.U., Crossey, M.J. and Glew, R.H, Nutritional factors associated with anaemia in pregnant women in northern Nigeria, Journal of Health Population and Nutrition, 25:75-81. 2007.
[8]	Yapo, P.A., Bleyere, M.N., Joulia-Ekaza, D., Yao J.D., N’guessan, B.B. and Ehile, E.E, Prévalence de carences martiales et d’anémies chez des femmes en âge de procréer, non enceintes et des femmes enceintes. Annale de Biologie Clinique Québec, 45 (3):24-28. 2008.
[9]	Wajcman, H., Lantz, B. and Girot, R, Les maladies du globule rouge. Paris, INSERM, Médecine-Sciences, 81-456. 1992.
[10]	Meda, N., Mandelbrot, L., Cartoux, M., Dao, B., Ouangre, A. and Dabis, F, Anémie de grossesse au Burkina Faso (Afrique de l’Ouest), 1995-1996: Prévalence et facteurs associés, Bulletin of World Health Organisation, 77(11):916-922. 2000.
[11]	Yip, R. and Dallman, P, The roles of inflammation and iron deficiency as causes of anemia, American Journal of Clinical Nutrition, 48:1295-300. 1988.
[12]	Semba, R.D., Taha, E.T., Kumwenda, N., Mtimavalye, L., Broadhead, R., Miotti, P.G. and Chiphangwi, J.D, Iron status and indicators of human immunodeficiency virus disease severity among pregnant women in Malawi, Clinical Infectious Disease, 32:1496-9. 2001.
[13]	Ramon, R., Sawadogo, D., Koko, F.S., Noba, V., Likikouet, R., Gourvellee, G., Viho, I., Mandelbrot, L., Dabis, F., Ekra, C.W. and Msellati, P, Haematological characteristics and HIV status of pregnant women in Abidjan, Côte d’Ivoire, 1995-96, Transactions of the Royal Society of Tropical Medicine and Hygiene, 93(4):22-412. 1999.
[14]	Loko, M.A., Toure, S., Dakoury-Dogbo, N., Gabillard, D., Leroy, V. and Anglaret, X, Decreasing incidence of pregnancy by decreasing CD4 cell count in HIV-infected women in Cote d’Ivoire: a 7-year cohort study, AIDS, 19:443-445. 2005.
[15]	Vernet, M., Corberand, J. and David, V, Algorithmes de prescription recommandés pour le diagnostic d’un déficit et d’une surcharge en fer, Annale de Biologie Clinique (Paris), 59: 149-55. 2001.
[16]	Institute of Medecine (IOM/USA), Comittte on nutritional status during pregnancy and lactation. Nutrition during pregnancy: weight gain and nutrient supplements. Washington DC. National Academy Press, 1990
[17]	UNICEF/UNU/WHO, Iron deficiency anemia: assessment, prevention, and control. WHO/NHD/01.3 Geneva, Switzerland: WHO 2001.
[18]	SNDLF (Société de Nutrition et de Diététique de Langue Française): Anémies nutritionnelles (SNDLF), Cahier de Nutrition et Diététique, 36 (Hors série):76-81. 2001.
[19]	Statsoft, Statistica (Data Analysis Software System). Version 7.1 2005; available at www. Statsoft.com.
[20]	Ihaka, R. and Gentleman, R, R: a language for data analysis and graphics, Journal of Computational and Graphical Statistics, 5:299-314. 1996.
[21]	Oladeinde, B.H., Phil, R.M., Olley, M. and Anunibe, J.A, Prevalence of HIV and anemia among pregnant women, North American Journal Medical Science, 3:548-51. 2011.
[22]	Beaton, G.H, Iron needs during pregnancy: do we need to rethink our targets, American Journal of Clinical Nutrition, 72: 265S-271S. 2000.
[23]	Dillon, J.C, Prévention de la carence en fer et des anémies ferriprives en milieu tropical, Medecine Tropicale, 60: 83-91. 2000.
[24]	Oguntona, C.R.B. and Akinyele, I.O, Food and nutrient intakes by pregnant Nigerian adolescents during the third trimester, Nutrition, 18: 673-679. 2002.
[25]	Ogbodo, S.O., Nwagha, U.I., Okaka, A.N.C., Okeke, A.C., Chukwurah, F.E. and Ezeonu, P.O, Low levels of some nutritional parameters of pregnant women in a rural community of South East Nigeria: Implications for the attainment of the millennium developmental goal, Annals of Medical and Health Sciences Research, 2(1):49-55. 2012.
[26]	Okwa, O.O, Tropical parasitic diseases and women. Annals of African Medicine 6:157-63. 2007.
[27]	WHO, Nutrient requirements for people living with HIV/AIDS: report of a technical consultation, Geneva, Switzerland. 2003. http:/www.who.org/publications/index.html [accessed May 14, 2012].
[28]	Walsh, C.M., Hattingh, Z., Veldman, F.J. and Bester, C.J, Iron status and anaemia of chronic disease in HIV-infected African women in Mangaung, Bloemfontein, South African Family Practice, 55-59. 2010.
[29]	Tsiakalos, A., Kordossis, T., Ziakas, P.D., Kontos, A.N., Kyriaki, D. and Sipras, N.V, Circulating antibodies to endogenous erythropoietin and risk for hiv-1 related anemia, Journal of infection, 60(3): 238-43. 2009.
[30]	Boelaert, J.R., Weinberg, G.A. and Weinberg, E.D, Altered iron metabolism in HIV infection: mechanisms, possible consequences, and proposals for management, Infectious agents and disease, 5(1): 36-46. 1996.
[31]	Semba, R.D., Shah, N., Strathdee, S.A. and Vlahov, D, High prevalence of iron deficiency and anemia among female injection drug users with and without HIV infection, Journal of Acquired Immune Deficiency Syndromes, 29:142-144. 2002.
[32]	Salome, M.A. and Grotto, H.Z, Human immunodeficiency virus-related anaemia of chronic disease: Relationship to hematologic, immune, and iron metabolism parameters, and lack of association with serum interferon-gamma levels, AIDS Patient Care and STDS, 16:361-5. 2002.
[33]	Handelman, G.J. and Levin, N.W, Iron and anemia in human biology: a review of mechanisms. Heart Failure Reviews, 13(4):393-404. 2008.
[34]	Semba, R.D, Iron-deficiency anaemia and the cycle of poverty among human immunodeficiency virus-infected women in the inner city, Clinical Infectious Diseases, 37:S105-11. 2003.
[35]	Alani, A., Vincent, O., Adewumi, A., Titilope, A., Onogu, E., Ralph, A. and Hab, C, Plasma folate studies in HIV-positive patients at the Lagos university teaching hospital, Nigeria, Indian Journal of Sexually Transmitted Diseases, 31:99-103. 2010.
[36]	Kurz, K., Seifert, M., Sarcletti, M., Fuchs, D., Weiss, G. and Zangerle, R, Iron metabolic changes and immune activation in patients with HIV-1 infection before and after one year of effective antiretroviral therapy, AIDS-XVIII International AIDS Conference, Abstract no. CDB0042. 2010.
[37]	Castaldo, A., Tarallo, L., Palomba, E., Albano, F., Russo, S., Zuin G., Guarino, B.F.A, Iron deficiency and intestinal malabsorption in HIV disease, Journal of Pediatric Gastroenterology and Nutrition, 22:359-63. 1996.
[38]	Baum, M.K., Shor-Posner, G. and Lu, Y, Micronutrients and HIV-1 disease progression, AIDS, 9:1051-1056. 1995.
[39]	Drain, P.K., Kupka, R., Mugusi, F. and Fawzi, W.W, Micronutrients in HIV-positive persons receiving highly active antiretroviral therapy, American Journal of Clinical Nutrition, 85:333-45. 2007.
[40]	Raiten, D.J, Nutrition and pharmacology: general principles and implications for HIV, American Journal of Clinical Nutrition, 94: 1667S-1676S. 2011.